HOUSTON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback